NANOVIRICIDES, INC. Adjustments to Additional Paid in Capital, Other
NANOVIRICIDES, INC. (NNVC) reported Adjustments to Additional Paid in Capital, Other of $83.90 thousand for the 12-month period ending 2014-06-30, per its 10-K filed 2016-09-16.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2016-09-16
- NANOVIRICIDES, INC. adjustments to additional paid in capital, other for the quarter ending 2014-06-30 was $0.00.
- NANOVIRICIDES, INC. adjustments to additional paid in capital, other for the quarter ending 2012-06-30 was $0.00.
- NANOVIRICIDES, INC. adjustments to additional paid in capital, other for the quarter ending 2012-03-31 was $0.00.
- NANOVIRICIDES, INC. adjustments to additional paid in capital, other for the quarter ending 2011-12-31 was $0.00.
- NANOVIRICIDES, INC. adjustments to additional paid in capital, other for fiscal 2014 was $83.90K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-16 | $83.90K 10-K · filed 2016-09-16 | ||
| 2014-03-31 | $83.90K 10-Q · filed 2014-05-15 | |||
| 2012-06-30 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2012-11-19 | $0.00 derived: sum of 2 quarters · filed 2012-11-19 | $0.00 derived: sum of 3 quarters · filed 2012-11-19 | $0.00 10-Q · filed 2012-11-19 |
| 2012-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-21 | $0.00 derived: sum of 2 quarters · filed 2012-05-21 | $0.00 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-02-14 | $0.00 10-Q · filed 2012-02-14 | ||
| 2011-09-30 | $0.00 10-Q/A · filed 2011-12-12 | |||
| 2011-06-30 | $33.00 10-Q/A · filed 2013-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |